Decision: Favourable

Decisions Table

Study Title:

A Pivotal Phase 3 Randomized, Placebo-controlled Clinical Study to Evaluate the Efficacy and Safety of the sGC Stimulator Vericiguat/MK-1242 in Adults With Chronic Heart Failure With Reduced Ejection Fraction.

  • NREC Code:

    21-NREC-CT-071

  • Decision:

    Favourable

  • Meeting Date:

    01/09/2021

  • Study Type:

    CT application

  • Principal Investigator:

    Professor Kenneth McDonald

  • PI Institution:

    St Michael's Hospital

  • Sponsor:

    MSD

Scroll to Top